Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Lubbe

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
The New Zealand Medical Journal|July 28, 1982
Amiodarone: its side effects, adverse reactions and dosage schedulesW F Lubbe, C J Mercer
The New Zealand Medical Journal|September 9, 1981
Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancyW F Lubbe, J V Hodge
Journal of Molecular and Cellular Cardiology|October 1, 1987
Metabolic basis of increased vulnerability to fibrillation in myocardial ischaemiaW F Lubbe, L H Opie
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockadeW F Lubbe, D A White
Journal of the American College of Cardiology|June 1, 1992
Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitorsW F Lubbe, T Podzuweit, L H Opie
Journal of the American College of Cardiology|May 1, 1983
Antiarrhythmic action of labetalol and its effect on adenine metabolism in the isolated rat heartW F Lubbe, T Nguyen, M F Edwards
The New Zealand Medical Journal|December 8, 1982
Hepatic and splenic haemorrhage as a complication of toxaemia of pregnancy in a patient with circulating lupus anticoagulantW F Lubbe, P Walkom, C J Alexander
Federation Proceedings|May 15, 1983
Modulation of myocardial cyclic AMP and vulnerability to fibrillation in the rat heartW F Lubbe, T Nguyen, E J West
Lancet (London, England)|February 14, 1976
Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugsT Podzuweit, W F Lubbe, L H Opie
The New England Journal of Medicine|November 21, 1985
Antiphospholipid antibodies and pregnancyW F Lubbe, N Pattison, G C Liggins
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
The New Zealand Medical Journal|July 28, 1982
Amiodarone: its side effects, adverse reactions and dosage schedulesW F Lubbe, C J Mercer
The New Zealand Medical Journal|September 9, 1981
Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancyW F Lubbe, J V Hodge
Journal of Molecular and Cellular Cardiology|October 1, 1987
Metabolic basis of increased vulnerability to fibrillation in myocardial ischaemiaW F Lubbe, L H Opie
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockadeW F Lubbe, D A White
Journal of the American College of Cardiology|June 1, 1992
Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitorsW F Lubbe, T Podzuweit, L H Opie
Journal of the American College of Cardiology|May 1, 1983
Antiarrhythmic action of labetalol and its effect on adenine metabolism in the isolated rat heartW F Lubbe, T Nguyen, M F Edwards
The New Zealand Medical Journal|December 8, 1982
Hepatic and splenic haemorrhage as a complication of toxaemia of pregnancy in a patient with circulating lupus anticoagulantW F Lubbe, P Walkom, C J Alexander
Federation Proceedings|May 15, 1983
Modulation of myocardial cyclic AMP and vulnerability to fibrillation in the rat heartW F Lubbe, T Nguyen, E J West
Lancet (London, England)|February 14, 1976
Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugsT Podzuweit, W F Lubbe, L H Opie
The New England Journal of Medicine|November 21, 1985
Antiphospholipid antibodies and pregnancyW F Lubbe, N Pattison, G C Liggins
Pageof 8